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Background: Balkan Endemic Nephropathy (BEN) is late-onset kidney disease thought to arise from chronic
exposure to aristolochic acid, a phytotoxin that contaminates wheat supplies in rural areas of Eastern Europe. It has
recently been demonstrated that humans are capable of perceiving aristolochic acid at concentrations below 40
nM as the result of high-affinity interactions with the TAS2R43 bitter taste receptor. Further, TAS2R43 harbors
high-frequency loss-of-function mutations resulting in 50-fold variability in perception. This suggests that genetic
variation in TAS2R43 might affect susceptibility to BEN, with individuals carrying functional forms of the receptor
being protected by an ability to detect tainted foods.
Methods: To determine whether genetic variation in TAS2R43 predicts BEN susceptibility, we examined
genotype-phenotype associations in a case–control study. A cohort of 88 affected and 99 control subjects from
western Bulgaria were genotyped with respect to two key missense variants and a polymorphic whole-gene
deletion of TAS2R43 (W35S, H212R, and wt/Δ), which are known to affect taste sensitivity to aristolochic acid. Tests
for association between haplotypes and BEN status were then performed.
Results: Three major TAS2R43 haplotypes observed in previous studies (TAS2R43-W35/H212, -S35/R212 and –Δ) were
present at high frequencies (0.17, 0.36, and 0.47 respectively) in our sample, and a significant association between
genotype and BEN status was present (P= 0.020; odds ratio 1.18). However, contrary to expectation, BEN was positively
associated with TAS2R43-W35/H212, a highly responsive allele previously shown to confer elevated bitter sensitivity to
aristolochic acid, which should drive aversion but might also affect absorption, altering toxin activation.
Conclusions: Our findings are at strong odds with the prediction that carriers of functional alleles of TAS2R43 are
protected from BEN by an ability to detect and avoid aristolochic acid exposure. Evidence for a positive association
between high-sensitivity alleles and BEN status suggests instead that possession of toxin-responsive receptor variants
may paradoxically increase vulnerability, possibly by shifting attractive responses associated with low-intensity bitter
sensations. The broad-spectrum tuning of the ~25-member TAS2R family as a whole toward xenobiotics points to a
potentially far-reaching relevance of bitter responses to exposure-related disease in both individuals and populations.Background
Balkan endemic nephropathy (BEN) is a late-onset kid-
ney disease occurring at high frequency in localized
areas of Eastern Europe [1-4]. Following asymptomatic
early stages, affected individuals suffer progressive devel-
opment of anemia, proteinuria, kidney atrophy, high
rates of urothelial cancer, and eventually death [1]. BEN’s
geographical distribution, which is restricted to rural* Correspondence: stephen.wooding@utsouthwestern.edu
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reproduction in any medium, provided the oragricultural areas, along with non-familial aspects of in-
heritance, suggested as early as the 1950s that the dis-
ease is caused by an environmental agent [5]. Recent
findings on BEN’s molecular pathology, including an en-
richment of aristoclactam-DNA adducts in tumor tis-
sues, have demonstrated that it arises from exposure to
aristolochic acid, a potent nephrotoxin produced by
plants in the genus Aristolochia [6] (Figure 1). This com-
pound enters food supplies when the seeds of Aristolo-
chia clematitis, a weed common in wheat fields, are
unintentionally harvested along with the crop [5].al Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 Epidemiological and biological background. A Location of study population. B Aristolochia clematitis plant, flower, and seeds [7].
C Pathway from aristolochic acid exposure to mutagenesis (modified from [8] Figure 6.) D Mechanism of taste response to aristolochic acid.
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plants, which utilize a constellation of secondary meta-
bolites to deter herbivores, including compounds tar-
geted at fundamental biological processes such as
embryonic development (e.g., cyclopamine), hormonal
homeostasis (e.g., goitrin), and protein synthesis (e.g.,
ricin). Numerous plant toxins are perceived as bitter,
even at low concentrations, and it has long been
hypothesized that bitter sensitivity serves as “toxin de-
tector” that enables animals to identify and avoid dan-
gerous foods [9]. The importance of this role declined in
humans with the advent of technological innovations
such as domestication and industrial processing. How-
ever, bitter taste retains health relevance as a mediator
of toxic exposures via contamination and spoilage
[10,11]. Further, the range of compounds perceived as
bitter extends beyond natural sources to include many
pharmaceuticals and synthetic agents, suggesting that
bitter responses may mediate clinically-significant expo-
sures in man-made environments [12,13]. Nonetheless,
specific instances of taste-toxin interaction, which are
likely to be informative about both the underlying
mechanisms and epidemiological consequences of ex-
posure, remain poorly documented.
Isolation of aristolochic acid from A. clematitis con-
firmed more than a century ago that it is abundant inthe plant and, like many phytotoxins, possesses aversive
taste characteristics [14]. Whether bitter perception
plays a role in regulating aristolochic acid exposure has
remained unknown; however, Pronin et al. [15] recently
demonstrated that humans are capable of perceiving
aristolochic acid at concentrations lower than any other
natural compound identified to date, with some subjects
reliably detecting it at just 40 nanomolar. Further, indivi-
duals vary more than 50-fold in threshold sensitivity as
the result of high-frequency loss-of-function mutations
in TAS2R43, a bitter taste receptor exhibiting high affinity
for aristolochic acid [12,15,16]. These findings suggest that
variation in TAS2R43 could be an important mediator of
BEN susceptibility, with high-function alleles conferring
protection by recognizing tainted foods. If so, genotype
could be a useful tool for predicting clinically-significant
vulnerability in individuals or populations. To examine
this relationship, we performed a case–control study test-
ing for association between mutational variants in
TAS2R43 and disease status in a BEN-affected population.
Methods
Subjects
Subjects were recruited from the Vraza-Sofia region of
Bulgaria as part of an ongoing epidemiological study
[3,17,18]. The case group was composed of 88 non-related
Wooding et al. BMC Medical Genetics 2012, 13:96 Page 4 of 7
http://www.biomedcentral.com/1471-2350/13/96BEN patients (20% male and 80% female; mean age
63± 14 years). Diagnosis was made based on several con-
sensus criteria: place of birth and residence in an endemic
village, family history of endemic nephritis, anemia,
specific color of face and palms, absence of arterial
hypertension, proteinuria, low specific gravity of the urine,
retention of nitrous compounds in the blood (urea >8.3
mMol/L, creatinine >133 μMol/L), and shrunken kidneys.
Seven were diagnosed with renal cancer and four with
bladder cancer. The control group was composed of 99
non-related healthy volunteers without family history of
renal disease or cancer, and matched with cases for sex
(25% male and 75% female) and age (58 ± 10 years). Writ-
ten informed consent was obtained from all participants
under human subject protocols in compliance with the
Helsinki Declaration, which were approved by the home
institution of DT, the Medical University of Sofia.
Genotyping
In a previous study of genetic effects on aristolochic acid
perception, Pronin et al. [15] demonstrated that two
tightly linked single-nucleotide polymorphisms (SNPs) in
TAS2R43, C104G/S35W and A635G/H212R (rs68157013
and rs71443637), define functionally divergent alleles
associated with threshold detection in subjects. While
TAS2R43-W35/H212 exhibits strong response in heterol-
ogous expression assays (EC50 = 8 nM) and is associated
with high taste sensitivity, TAS2R43-S35/R212 exhibits
weaker response (EC50= 73 nM) and is associated with
low sensitivity. Some evidence suggests that a second bit-
ter taste receptor, TAS2R44, may contribute to aristo-
lochic acid perception; however, functional assays indicate
that TAS2R44 is substantially less responsive than is
TAS2R43, and variation in TAS2R44 is not associated with
taste sensitivity [15]. Therefore, only the TAS2R43-W35/
H212 and -S35/R212 SNPs were considered as candidates
in our study. To determine subject genotypes with respect
to these two variants, we utilized allelic discrimination
assays, which were carried out using an Applied Biosys-
tems Incorporated (ABI) HT7900 Real-Time PCR system
with TaqMan probes and reagents purchased from ABI.
Phenotypic measures of taste response to aristolochic acid,
which were obtained from healthy subjects by Pronin
et al. [15], were not obtained in our subjects owing to the
dangers of further exposing an at-risk population.
Copy-number assays
In addition to the C104G/S35W and A635G/H212R muta-
tions,TAS2R43 is known to harbor a high-frequency whole-
gene deletion allele (TAS2R43-Δ) in European populations
[15,19]. To characterize genotypes with respect to the dele-
tion, we performed copy-number assays using methods and
reagents developed by Roudnitzky et al. [19]. In brief, we uti-
lized a real-time quantitative PCR incorporating two primersets and two fluorescently labeled TaqManWMGB probes to
determine whether a given subject harbored 0 copies of
TAS2R43 (i.e., is homozygous for the deletion), 1 copy (het-
erozygous for the deletion), or 2 copies (does not carry the
deletion). These data were then combined with the SNP
data using the method of Roudnitzky et al. [19] to produce
final genotypes, which were characterized by three alleles, C,
G, and Δ at position 104 and A, G, Δ at position 635.
Association tests
Tests for association between TAS2R43 mutations and
BEN were performed using the R statistical package
[20]. To take into account co-dominance effects identi-
fied in previous studies of association, which have found
that individuals heterozygous with respect to function-
ally divergent TAS2R variants display intermediate phe-
notypes, subjects were coded as carrying 0, 1, or 2
copies of the functionally responsive TAS2R43-W35/
H212 allele. Fisher’s Exact tests were then performed
on a contingency table of genotype with respect to
functional alleles and case/control status. The results
of these analyses were confirmed using linear regres-
sion and χ2 tests.
Results and discussion
Previous studies have demonstrated that the TAS2R43
bitter taste receptor is a key mediator of aristolochic acid
perception. Functional forms of the receptor exhibit de-
tectable responses at concentrations of ~10 nanomolar
in heterologous expression assays, and some individuals
reliably perceive aristolochic acid at concentrations as
low as 40 nanomolar [15,16]. It has also been demon-
strated that ability to perceive aristolochic acid is influ-
enced by common functional mutations in TAS2R43
including two tightly linked amino acid variants, C104G/
S35W and A635G/H212R (rs68157013 and rs71443637),
and a whole-gene deletion, TAS2R43-Δ. While TAS2R43-
W35/H212 exhibits strong response to aristolochic acid in
heterologous expression assays and is associated with low
threshold detection (i.e., high taste sensitivity), TAS2R43-
S35/R212 and TAS2R43-Δ exhibit weak or no response
and are associated with high threshold (i.e., low sensitivity).
These findings have suggested that variation in TAS2R43
might affect susceptibility to BEN, with TAS2R43-W35/
H212 conferring protection by signaling aristolochic acid
contamination in food.
SNP genotyping and copy-number determination revealed
that the three major functional variants of TAS2R43
(TAS2R43-W35/H212, -S35/R212 and –Δ) were all com-
mon in our sample, with frequencies of 0.17, 0.36, and 0.47
respectively. No recombinant variants of TAS2R43-W35/
H212 and -S35/R212 (e.g., -W35/R212) were observed, such
that W35S and H212R were in perfect linkage disequilib-
rium (LD) (r2=1). These patterns are consistent with those
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of 0.15, 0.35, and 0.50 in a similar panel of European sub-
jects, with tight linkage (r2=1) between W35S and H212R.
Overall, 2.7% (n=5) of subjects were homozygous for the
TAS2R43-W35/H212 allele, 29.4% (n=55) were heterozy-
gous, and 67.9% (n=127) were non-carriers (Figure 2).
Again, these values are comparable to those observed by
Roudnitzky et al. [19] (3.3%, 23.3%, and 73.3%). Thus, levels
and patterns of variation in our sample appear to be typical
for European populations. However, they are not necessarily
typical for other populations. Pilot data from the 1000 Gen-
omes Project (1000GP), a consortium-based effort to se-
quence more than 2000 complete human genomes with
worldwide representation, indicate that TAS2R43-S35/R212
is present at frequencies <3% in Asian populations [21].
Association tests detected a significant relationship be-
tween TAS2R43-W35/H212 carrier status and BEN; how-
ever, counter to expectation, the correlation was positive,
not negative as would be predicted if perception of aristo-
lochic acid leads to avoidance (Figure 3). Fisher’s exact test
yielded a P-value of 0.020, with the case population being
enriched with TAS2R43-W35/H212. Tests using linear
regression indicated the presence of an effect with an
estimated odds ratio of 1.18 (P= 0.025). Similar P-values
were obtained using linear regression (P= 0.021; β=0.16;
r2 = 0.11) and χ2 tests (χ2=0.74; P= 0.025). Thus, signifi-
cance levels were not sensitive to the analytical model.
These findings are at odds with the prediction thatFigure 2 Genetic data. A Occurrence of TAS2R43-W35/H212, -S35/R212
and Δ alleles in subjects. Counts are given, with frequencies shown in
parentheses. B Genotype frequencies in subjects.aristolochic acid-sensitive TAS2R43 alleles provide an ef-
fective safeguard against overexposure, and raise the para-
doxical possibility that they instead confer susceptibility.
Evidence that aristolochic acid-sensitive alleles confer
increased susceptibility to BEN is striking and counterin-
tuitive. Bitter perception has long been hypothesized to
provide protection against toxins in the environment, par-
ticularly plant toxins, by enabling detection and avoidance
[22]. This hypothesis is supported by much circumstantial
evidence: bitter tastes are generally aversive, plant-derived
toxins are over-represented among known bitter tastants,
bitter taste receptors respond to many well-known toxins,
and plants containing these toxins are perceived as bitter
[9,12]. Thus, the clear prediction under the toxin-detector
hypothesis is that TAS2R43-W35/H212, which has been
shown to be associated with low taste thresholds for aris-
tolochic acid, should provide a warning signal providing
protection against BEN or, if aristolochic acid concentra-
tions are too low to perceive, have no effect on susceptibil-
ity. Our finding that TAS2R43-W35 is positively, rather
than negatively, associated with BEN is strongly at odds
with this prediction.
One explanation for our findings could be that, con-
trary to expectations, the bitter taste of aristolochic acid
is attractive to those who perceive it, rendering them
susceptible to disease-causing levels of exposure. This
explanation conflicts with predictions under the toxin-
detector hypothesis; however, it is consistent with psy-
chophysical studies, which have revealed that while in-
tense bitter sensations are universally aversive, mild
sensations can evoke positive responses [23]. PositiveFigure 3 Association data and tests. A Frequencies of genotypes
with respect to functionally divergent allele categories N
(Non-responsive to aristolochic acid; W35/H212) and R
(Responsive to aristolochic acid; S35/R212 and Δ). B Results of
regression, Fisher’s Exact, and Χ2 tests for association.
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many foods, such as beer and salad greens have bitter,
yet overall pleasurable, taste characteristics. This explan-
ation is consistent with evidence that BEN arises as the
result of chronic low-level exposures, which might be
perceived as pleasantly bitter, as opposed to acute high-
level exposures, which would likely be aversive.
A second, more speculative, explanation for our results
is suggested by reports that bitter taste receptors and
other major components of the taste transduction path-
way are expressed in the mammalian gut, as well as on
the tongue [24]. In mice and rats, Tas2R transcripts are
found in gastric and duodenal tissues, and cells derived
from intestinal tissue show dosage-dependent responses
to bitter tastants [25]. The native role of TAS2R-
mediated signaling in the gut remains unclear, but sig-
nals initiated by these receptors can induce the release
of signaling peptides from enteroendocrine cells [25].
Further, some evidence suggests that post-absorptive
metabolic activation of aristolochic acid is crucial to its
toxicity [26]. If the response of gut-expressed TAS2R43
to aristolochic acid enhances either absorption or me-
tabolism, then genetic variation in TAS2R43 might shape
susceptibility to BEN.
BEN’s distinctive pathology is not unique. Similar pat-
terns of kidney damage and increased rates of urothelial
cancer have emerged in subjects overexposed to herbal
supplements containing aristolochic acid [2]. Based on
the etiological similarities of these diseases, it has been
suggested that they be aggregated under an umbrella term,
aristolochic acid nephropathy (AAN). To date, efforts to
find genetic variants accounting for variable susceptibility
to AAN have been relatively unsuccessful. For instance,
variants in several genes (NQO1, GSTT1, GSTM1, NAT1,
and NAT2) found previously to be associated with
occupationally-induced renal and bladder cancers were
not associated with AAN diagnosis [17]. Our findings rec-
ommend that variation in TAS2R43 be considered a can-
didate factor in overall AAN susceptibility. While taste
sensitivity alone seems unlikely to account for variable ex-
posure aristolochic acid via nutritional supplements,
which are often encapsulated to disguise taste, TAS2R43
variation might exert effects through activity in the gut.
Conclusions
From clinical and epidemiological perspectives, our find-
ings have two primary implications. First, evidence that
mutational polymorphism TAS2R43 significantly affects
susceptibility to BEN points to a potentially broad role
for toxin responses in personal health risks. Most of
the ~25 known TAS2Rs in humans exhibit responses
to both phytotoxins and synthetic molecules, and
many harbor extensive genetic diversity [12,27]. Thus,
normal variation in taste or other TAS2R-mediatedtraits could be a appreciable contributing factor in in-
dividual exposure. Indications that susceptibility to
BEN arises, in part, from inherited mutations also has
epidemiological implications. In particular, it is well
established that mutations in TAS2R genes vary sub-
stantially in frequency among populations [27-29]. For
this reason, variation in TAS2R-mediated traits, and
therefore susceptibility, could differ among groups. This
possibility is exemplified by early results from the 1000GP,
which indicate that while TAS2R43-S35/R212 is present at
frequencies >30% in Europeans, it accounts for <3% of
alleles in Asian groups. We anticipate that advances in
large-scale in vitro deorphanization of TAS2Rs, which are
capable of rapidly identifying candidate receptor-agonist
interactions, will be a valuable tool in identifying and de-
termining the significance of these patterns.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
SPW and DT conceived and supervised all research activities. HCG performed
laboratory genetic analysis. SA, RS, and ID performed laboratory work and
sample preparation. All authors read and approved the final manuscript.
Acknowledgement
Support was provided in part by a grant from the Swiss National Science
Foundation to DT (SNSF IZ73ZO_127949/1).
Author details
1McDermott Center for Human Growth and Development, University of
Texas Southwestern Medical Center, Dallas, TX 75244, USA. 2Department of
Clinical Chemistry, Georg-August University, Robert-Koch-Strasse 40, 37075,
Göttingen, Germany. 3Department of Medical Genetics, Medical University of
Sofia, Sofia 1431, Bulgaria.
Received: 2 December 2011 Accepted: 28 September 2012
Published: 11 October 2012
References
1. Stefanovic V, Radovanovic Z: Balkan endemic nephropathy and associated
urothelial cancer. Nat Clin Pract Urol 2008, 5(2):105–112.
2. Debelle FD, Vanherweghem JL, Nortier JL: Aristolochic acid nephropathy:
A worldwide problem. Kidney Int 2008, 74(2):158–169.
3. Stefanovic V, Toncheva D, Atanasova S, Polenakovic M: Etiology of Balkan
endemic nephropathy and associated urothelial cancer. Am J Nephrol
2006, 26(1):1–11.
4. Toncheva D, Dimitrov T, Stojanova S: Etiology of Balkan endemic
nephropathy: a multifactorial disease? Eur J Epidemiol 1998, 14(4):389–394.
5. Hranjec T, Kovac A, Kos J, Mao W, Chen J, Grollman A, Jelakovic B: Endemic
nephropathy: the case for chronic poisoning by aristolochia. Croat Med J
2005, 46(1):116–125.
6. Grollman A, Jelakovic B: Role of environmental toxins in endemic
(Balkan) nephropathy. October 2006, Zagreb, Croatia. J Am Soc
Nephrol 2007, 18(11):2817–2823.
7. Sturm JG: Tafel 45, Deutschlands Flora in Abbildungen. Stuttgart, Germany;
1796.
8. Arlt V, Stiborova M, Brocke J, Simoes M, Lord G, Nortier J, Hollstein M,
Phillips D, Schmeiser H: Aristolochic acid mutagenesis: molecular clues to
the aetiology of Balkan endemic nephropathy-associated urothelial
cancer. Carcinogenesis 2007, 28(11):2253–2261.
9. Sandell M, Breslin P: Variability in a taste-receptor gene determines
whether we taste toxins in food. Curr Biol 2006, 16(18):R792–R794.
10. Cardoso AP, Mirione E, Ernesto M, Massaza F, Cliff J, Haque MR, Bradbury JH:
Processing of cassava roots to remove cyanogens. Journal of Food
Composition and Analysis 2005, 18(2005):451–460.
Wooding et al. BMC Medical Genetics 2012, 13:96 Page 7 of 7
http://www.biomedcentral.com/1471-2350/13/9611. Chiwona-Karltun L, Brimer L, Kalenga Saka JD, Rhone AR, Mkumbira J,
Johansson L, Bokanga M, Mahungu NM: Bitter taste in cassava roots
correlates with cyanogenic glucoside levels. Journal of Food Science and
Agriculture 2004, 84:581–590.
12. Meyerhof W, Batram C, Kuhn C, Brockhoff A, Chudoba E, Bufe B, Appendino
G, Behrens M: The molecular receptive ranges of human TAS2R bitter
taste receptors. Chem Senses 2010, 35(2):157–170.
13. Carrai M, Steinke V, Vodicka P, Pardini B, Rahner N, Holinski-Feder E, Morak
M, Schackert HK, Gorgens H, Stemmler S, et al: Association between
TAS2R38 gene polymorphisms and colorectal cancer risk: a case–control
study in two independent populations of Caucasian origin. PLoS One
2011, 6(6):e20464.
14. Hesse O: Aristolochia argentina. Pharm J 1896, 56:61.
15. Pronin A, Xu H, Tang H, Zhang L, Li Q, Li X: Specific alleles of bitter
receptor genes influence human sensitivity to the bitterness of aloin
and saccharin. Curr Biol 2007, 17(16):1403–1408.
16. Kuhn C, Bufe B, Winnig M, Hofmann T, Frank O, Behrens M, Lewtschenko T,
Slack JP, Ward CD, Meyerhof W: Bitter taste receptors for saccharin and
acesulfame K. J Neurosci 2004, 24(45):10260–10265.
17. Toncheva D, Von Ahsen N, Atanasova S, Dimitrov T, Armstrong V,
Oellerich M: Identification of NQO1 and GSTs genotype frequencies in
Bulgarian patients with Balkan endemic nephropathy. J Nephrol 2004,
17(3):384–389.
18. Atanasova S, von Ahsen N, Toncheva D, Dimitrov T, Oellerich M, Armstrong
V: Genetic polymorphisms of cytochrome P450 among patients with
Balkan endemic nephropathy (BEN). Clin Biochem 2005, 38(3):223–228.
19. Roudnitzky N, Bufe B, Thalmann S, Kuhn C, Gunn HC, Xing C, Crider BP,
Behrens M, Meyerhof W, Wooding SP: Genomic, genetic, and functional
dissection of bitter taste responses to artificial sweeteners. Hum Mol
Genet 2011, 20(17):3437–3449.
20. R Development Core Team: R: A Language and Environment for Statistical
Computing. Vienna, Austria: R Foundation for Statistical Computing; 2010.
21. The 1000 Genomes Project Consortium: A map of human genome
variation from population-scale sequencing. Nature 2010,
467(7319):1061–1073.
22. Sadtler RE: The chemistry of the formation of poisons in plants. Sci Mon
1929, 29:153–154.
23. Drewnowski A, Gomez-Carneros C: Bitter taste, phytonutrients, and the
consumer: a review. Am J Clin Nutr 2000, 72(6):1424–1435.
24. Rozengurt E: Taste receptors in the gastrointestinal tract. I. Bitter taste
receptors and alpha-gustducin in the mammalian gut. Am J Physiol
Gastrointest Liver Physiol 2006, 291(2):G171–G177.
25. Sternini C, Anselmi L, Rozengurt E: Enteroendocrine cells: a site of ‘taste’ in
gastrointestinal chemosensing. Curr Opin Endocrinol Diabetes Obes 2008,
15(1):73–78.
26. Stiborova M, Frei E, Arlt VM, Schmeiser HH: Metabolic activation of
carcinogenic aristolochic acid, a risk factor for Balkan endemic
nephropathy. Mutat Res 2008, 658(1–2):55–67.
27. Kim U, Wooding S, Ricci D, Jorde LB, Drayna D: Worldwide haplotype
diversity and coding sequence variation at human bitter taste receptor
loci. Hum Mutat 2005, 26(3):199–204.
28. Soranzo N, Bufe B, Sabeti PC, Wilson JF, Weale ME, Marguerie R, Meyerhof
W, Goldstein DB: Positive selection on a high-sensitivity allele of the
human bitter-taste receptor TAS2R16. Curr Biol 2005, 15(14):1257–1265.
29. Campbell MC, Ranciaro A, Froment A, Hirbo J, Omar S, Bodo JM, Nyambo T,
Lema G, Zinshteyn D, Drayna D, et al: Evolution of Functionally Diverse
Alleles Associated with PTC Bitter Taste Sensitivity in Africa. Mol Biol Evol
2012, 29(4):1141–1153.
doi:10.1186/1471-2350-13-96
Cite this article as: Wooding et al.: Association of a bitter taste receptor
mutation with Balkan Endemic Nephropathy (BEN). BMC Medical Genetics
2012 13:96.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
